32 results
424B3
COYA
Coya Therapeutics Inc
24 Jun 24
Prospectus supplement
5:31pm
person to distribute the securities. The Company is required to pay certain fees
and expenses incurred by the Company incident to the registration
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
to the Company.
4.20 Registration Expenses. All fees and expenses incident to the performance of or compliance with, Sections 4.18 and 4.19 … the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
424B3
y1h3zccsffds l9
16 Jan 24
Prospectus supplement
4:06pm
S-3
ltlp0sig07nh22v
4 Jan 24
Shelf registration
4:46pm
8-K
EX-10.1
mqht7z1de3w4a4hoq
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
b7sjtls
14 Jul 23
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
xmsw2oi
10 Jul 23
Departure of Directors or Certain Officers
5:08pm
10-K
c52trl 4vy5
29 Mar 23
Annual report
4:08pm
10-K
EX-3.2
t727jl3u5
29 Mar 23
Annual report
4:08pm
424B4
kjr 30oyj
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
bq3djc296x
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
EX-10.7
6op1is54zjqkac0m04w
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-10.3
5jcwofp2
18 Nov 22
IPO registration
5:06pm
S-1
EX-10.5
n1w2ni6
18 Nov 22
IPO registration
5:06pm
S-1
EX-10.6
fri i1zvf11sp
18 Nov 22
IPO registration
5:06pm